Antenatal nutritional supplementation and autism spectrum disorders in the Stockholm youth cohort: Population based cohort study

Elizabeth A. Devilbiss, Cecilia Magnusson, Renee M. Gardner, Dheeraj Rai, Craig Newschaffer, Kristen Lyall, Christina Dalman, Brian K. Lee

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective To determine whether nutritional supplementation during pregnancy is associated with a reduced risk of autism spectrum disorder (ASD) with and without intellectual disability in offspring. Design Observational prospective cohort study using multivariable logistic regression, sibling controls, and propensity score matching. Setting Stockholm County, Sweden. Participants 273 107 mother-child pairs identified through population registers. The study sample was restricted to children who were aged 4 to 15 years by the end of follow-up on 31 December 2011 and were born between 1996 and 2007. Exposures Multivitamin, iron, and folic acid supplement use was reported at the first antenatal visit. Main outcome measure Diagnosis of ASD with and without intellectual disability in children determined from register data up to 31 December 2011. Results Prevalence of ASD with intellectual disability was 0.26% (158 cases in 61 934) in the maternal multivitamin use group and 0.48% (430 cases in 90 480) in the no nutritional supplementation use group. Maternal multivitamin use with or without additional iron or folic acid, or both was associated with lower odds of ASD with intellectual disability in the child compared with mothers who did not use multivitamins, iron, and folic acid (odds ratio 0.69, 95% confidence interval 0.57 to 0.84). Similar estimates were found in propensity score matched (0.68, 0.54 to 0.86) and sibling control (0.77, 0.52 to 1.15) matched analyses, though the confidence interval for the latter association included 1.0 and was therefore not statistically significant. There was no consistent evidence that either iron or folic acid use were inversely associated with ASD prevalence. Conclusions Maternal multivitamin supplementation during pregnancy may be inversely associated with ASD with intellectual disability in offspring. Further scrutiny of maternal nutrition and its role in the cause of autism is recommended.

Original languageEnglish (US)
Article numberj4273
JournalBMJ (Online)
Volume359
DOIs
StatePublished - Jan 1 2017

Fingerprint

Cohort Studies
Intellectual Disability
Mothers
Folic Acid
Iron
Population
Propensity Score
Siblings
Confidence Intervals
Pregnancy
Autistic Disorder
Sweden
Registries
Autism Spectrum Disorder
Logistic Models
Odds Ratio
Outcome Assessment (Health Care)
Prospective Studies

All Science Journal Classification (ASJC) codes

  • Medicine(all)

Cite this

Devilbiss, Elizabeth A. ; Magnusson, Cecilia ; Gardner, Renee M. ; Rai, Dheeraj ; Newschaffer, Craig ; Lyall, Kristen ; Dalman, Christina ; Lee, Brian K. / Antenatal nutritional supplementation and autism spectrum disorders in the Stockholm youth cohort : Population based cohort study. In: BMJ (Online). 2017 ; Vol. 359.
@article{1dc5aaec2b2d48849eb174faf549ca07,
title = "Antenatal nutritional supplementation and autism spectrum disorders in the Stockholm youth cohort: Population based cohort study",
abstract = "Objective To determine whether nutritional supplementation during pregnancy is associated with a reduced risk of autism spectrum disorder (ASD) with and without intellectual disability in offspring. Design Observational prospective cohort study using multivariable logistic regression, sibling controls, and propensity score matching. Setting Stockholm County, Sweden. Participants 273 107 mother-child pairs identified through population registers. The study sample was restricted to children who were aged 4 to 15 years by the end of follow-up on 31 December 2011 and were born between 1996 and 2007. Exposures Multivitamin, iron, and folic acid supplement use was reported at the first antenatal visit. Main outcome measure Diagnosis of ASD with and without intellectual disability in children determined from register data up to 31 December 2011. Results Prevalence of ASD with intellectual disability was 0.26{\%} (158 cases in 61 934) in the maternal multivitamin use group and 0.48{\%} (430 cases in 90 480) in the no nutritional supplementation use group. Maternal multivitamin use with or without additional iron or folic acid, or both was associated with lower odds of ASD with intellectual disability in the child compared with mothers who did not use multivitamins, iron, and folic acid (odds ratio 0.69, 95{\%} confidence interval 0.57 to 0.84). Similar estimates were found in propensity score matched (0.68, 0.54 to 0.86) and sibling control (0.77, 0.52 to 1.15) matched analyses, though the confidence interval for the latter association included 1.0 and was therefore not statistically significant. There was no consistent evidence that either iron or folic acid use were inversely associated with ASD prevalence. Conclusions Maternal multivitamin supplementation during pregnancy may be inversely associated with ASD with intellectual disability in offspring. Further scrutiny of maternal nutrition and its role in the cause of autism is recommended.",
author = "Devilbiss, {Elizabeth A.} and Cecilia Magnusson and Gardner, {Renee M.} and Dheeraj Rai and Craig Newschaffer and Kristen Lyall and Christina Dalman and Lee, {Brian K.}",
year = "2017",
month = "1",
day = "1",
doi = "10.1136/bmj.j4273",
language = "English (US)",
volume = "359",
journal = "The BMJ",
issn = "0267-0623",
publisher = "BMJ Publishing Group",

}

Antenatal nutritional supplementation and autism spectrum disorders in the Stockholm youth cohort : Population based cohort study. / Devilbiss, Elizabeth A.; Magnusson, Cecilia; Gardner, Renee M.; Rai, Dheeraj; Newschaffer, Craig; Lyall, Kristen; Dalman, Christina; Lee, Brian K.

In: BMJ (Online), Vol. 359, j4273, 01.01.2017.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Antenatal nutritional supplementation and autism spectrum disorders in the Stockholm youth cohort

T2 - Population based cohort study

AU - Devilbiss, Elizabeth A.

AU - Magnusson, Cecilia

AU - Gardner, Renee M.

AU - Rai, Dheeraj

AU - Newschaffer, Craig

AU - Lyall, Kristen

AU - Dalman, Christina

AU - Lee, Brian K.

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Objective To determine whether nutritional supplementation during pregnancy is associated with a reduced risk of autism spectrum disorder (ASD) with and without intellectual disability in offspring. Design Observational prospective cohort study using multivariable logistic regression, sibling controls, and propensity score matching. Setting Stockholm County, Sweden. Participants 273 107 mother-child pairs identified through population registers. The study sample was restricted to children who were aged 4 to 15 years by the end of follow-up on 31 December 2011 and were born between 1996 and 2007. Exposures Multivitamin, iron, and folic acid supplement use was reported at the first antenatal visit. Main outcome measure Diagnosis of ASD with and without intellectual disability in children determined from register data up to 31 December 2011. Results Prevalence of ASD with intellectual disability was 0.26% (158 cases in 61 934) in the maternal multivitamin use group and 0.48% (430 cases in 90 480) in the no nutritional supplementation use group. Maternal multivitamin use with or without additional iron or folic acid, or both was associated with lower odds of ASD with intellectual disability in the child compared with mothers who did not use multivitamins, iron, and folic acid (odds ratio 0.69, 95% confidence interval 0.57 to 0.84). Similar estimates were found in propensity score matched (0.68, 0.54 to 0.86) and sibling control (0.77, 0.52 to 1.15) matched analyses, though the confidence interval for the latter association included 1.0 and was therefore not statistically significant. There was no consistent evidence that either iron or folic acid use were inversely associated with ASD prevalence. Conclusions Maternal multivitamin supplementation during pregnancy may be inversely associated with ASD with intellectual disability in offspring. Further scrutiny of maternal nutrition and its role in the cause of autism is recommended.

AB - Objective To determine whether nutritional supplementation during pregnancy is associated with a reduced risk of autism spectrum disorder (ASD) with and without intellectual disability in offspring. Design Observational prospective cohort study using multivariable logistic regression, sibling controls, and propensity score matching. Setting Stockholm County, Sweden. Participants 273 107 mother-child pairs identified through population registers. The study sample was restricted to children who were aged 4 to 15 years by the end of follow-up on 31 December 2011 and were born between 1996 and 2007. Exposures Multivitamin, iron, and folic acid supplement use was reported at the first antenatal visit. Main outcome measure Diagnosis of ASD with and without intellectual disability in children determined from register data up to 31 December 2011. Results Prevalence of ASD with intellectual disability was 0.26% (158 cases in 61 934) in the maternal multivitamin use group and 0.48% (430 cases in 90 480) in the no nutritional supplementation use group. Maternal multivitamin use with or without additional iron or folic acid, or both was associated with lower odds of ASD with intellectual disability in the child compared with mothers who did not use multivitamins, iron, and folic acid (odds ratio 0.69, 95% confidence interval 0.57 to 0.84). Similar estimates were found in propensity score matched (0.68, 0.54 to 0.86) and sibling control (0.77, 0.52 to 1.15) matched analyses, though the confidence interval for the latter association included 1.0 and was therefore not statistically significant. There was no consistent evidence that either iron or folic acid use were inversely associated with ASD prevalence. Conclusions Maternal multivitamin supplementation during pregnancy may be inversely associated with ASD with intellectual disability in offspring. Further scrutiny of maternal nutrition and its role in the cause of autism is recommended.

UR - http://www.scopus.com/inward/record.url?scp=85030653062&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030653062&partnerID=8YFLogxK

U2 - 10.1136/bmj.j4273

DO - 10.1136/bmj.j4273

M3 - Article

C2 - 28978695

AN - SCOPUS:85030653062

VL - 359

JO - The BMJ

JF - The BMJ

SN - 0267-0623

M1 - j4273

ER -